PLx Pharma Inc reports results for the quarter ended in September - Earnings Summary

PLx Pharma Winddown

12/11/2021 14:30

* PLx Pharma Inc  PLXP.OQ  reported a quarterly adjusted loss
of 80 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 46 cents per share.
* Revenue was $6.62 million​;  analysts expected $4.10 million. 
* PLx Pharma Inc's reported EPS for the quarter was a loss of 80
cents​.
* The mean earnings estimate of analysts had fallen by
about 1.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* PLx Pharma Inc shares had fallen by 32.4% this quarter and
gained 136.2% so far this year.
* The company reported a quarterly loss of $21.64 million.
* Wall Street's median 12-month price target for PLx Pharma Inc
is $22.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 12 at 02:30 p.m.
 ​All figures in US dollars unless otherwise stated